Current Priority Management Issues and Business Strategy

from the beginning

Current Priority Management Issues and Business Strategy

Contents

Performance Trends

• FY2018 1H vs. FY2017 1H

• FY2018 1H Core Operating Income by Sector vs. FY2017 1H

• Dividend Policy

Progress on Corporate Business Plan (Overall)

• Corporate Business Plan: Basic Policy

• FY2018 Forecast vs. FY2018 Target

• Corporate Business Plan: Medium- to Long-term vs. FY2018 Performance Targets

• Capital Expenditure and Investment Forecast for FY2016-FY2018 (decision-making basis)

• Capital Expenditure and Investment Plan for FY2016-FY2018 (decision-making basis)

• Research and Development Expenses Plan for FY2016-FY2018

• Major Investments and Commercialization Schedule (Overall)

• Major Investments and Commercialization Schedule (Overall)

• Change in Business Portfolio

• Changes in Our Business Portfolio

• Management of Cash Flow

Business Strategy and Topics (by Sector)

• Petrochemicals & Plastics: Challenges and Business Strategy and Progress Status

• Petrochemicals & Plastics: Expanding the Technology Licensing Business

• Petrochemicals & Plastics: Rabigh Phase II Project

• Energy & Functional Materials: Challenges and Business Strategy/Progress

• Energy & Functional Materials: Expand the Lithium-ion Secondary Battery Separators Business

• Energy & Functional Materials: Expansion of Liquid Crystal Polymer (LCP) business

• IT-related Chemicals: Challenges and Business Strategy/Progress on Strategic Initiatives

• IT-related Chemicals: Business Development for Medium-size Displays Applications

• IT-related Chemicals: Commercialization of Polymer OLED Materials

• IT-related Chemicals: Compound Semiconductor Business Development for Automotive Applications

• Major Products in the Mobility Sector

• Health & Crop Sciences: Challenges and Business Strategy/Progress on Strategic Initiatives

• Health & Crop Sciences: Strengthening Crop Protection Business India

• Health & Crop Sciences: Progress in Pipeline Development

• Health & Crop Sciences: Expansion of Our Biorational Business

• Pharmaceuticals: Progress on Strategic Initiatives

• Status of LATUDA ANDA litigations (U.S. Patent No.9,815,827 / 9,907,794)

• Pharmaceuticals: Initiatives in Regenerative Medicine & Cell Therapy Business

• Pharmaceuticals: Initiatives in Nucleic Acid Medicine

• Pharmaceuticals: Nihon Medi-Physics Expansion of Healthcare Businesses

Direction of Future Business Strategy

• Management Strategy and Performance Trends from the early 21st century

• Current Management Strategy and Performance Trends: Management by Phase

• Initiatives for Global Environment Issues

• Initiatives for Global Environment Issues

• Initiatives for Global Environment Issues

• Initiatives for Global Environmental Issues

• The Issue of Plastic Waste

• The Issue of Plastic Waste

• Drastic Improvement of Productivity through Digital Innovation

• Digital Innovation in Production and Research

• Digital Innovation in Production and Research

Digital Innovation in Production and Research

• Initiatives to Accelerate Innovation

• Collaboration with Start-up Companies

• Promote Open Innovation

• Promote Open Innovation

• Initiatives for Sustainability

• Initiatives for Sustainability (External Evaluation)

• Held the Second Sustainability Promotion Committee

• What Sumitomo Chemical Strives To Be

Cautionary Statement